PPARD and breast carcinoma: It is interesting to note that the roles of PPAR signalling in cancer has been well documented in the literature [32, 33], and recently there is evidence to suggest that PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy [34], and the activation of PPAR beta can inhibit human breast cancer cell line tumorigenicity.